Location: Fort Worth, TX
CIK: 0001536054 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $53.48M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DNLI | DENALI THERAPEUTICS INC | 1,910,732 | $49.14M | 91.9% | — | — | COM | 24823R105 |
| SANA | SANA BIOTECHNOLOGY INC | 755,736 | $2.638M | 4.9% | — | — | COM | 799566104 |
| EGHT | 8X8 INC NEW | 990,850 | $1.694M | 3.2% | — | — | COM | 282914100 |